BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Apollos JR, Sami S, Prasanth MN, Jeyakumar J, McFadyen AK. Pre-diagnostic delays caused by gastrointestinal investigations do not affect outcomes in pancreatic cancer. Ann Med Surg (Lond) 2018;34:66-70. [PMID: 30254746 DOI: 10.1016/j.amsu.2018.07.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Sapalidis K, Kosmidis C, Funtanidou V, Katsaounis A, Barmpas A, Koimtzis G, Mantalobas S, Alexandrou V, Aidoni Z, Koulouris C, Pavlidis E, Giannakidis D, Surlin V, Pantea S, Strambu V, Constantina RO, Amaniti A, Zarogoulidis P, Mogoantă S, Kesisoglou I, Sardeli C. Update on current pancreatic treatments: from molecular pathways to treatment. J Cancer 2019;10:5162-72. [PMID: 31602269 DOI: 10.7150/jca.36300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Silveira EA, da Silva Filho RR, Spexoto MCB, Haghighatdoost F, Sarrafzadegan N, de Oliveira C. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications. Int J Mol Sci 2021;22:4339. [PMID: 33919368 DOI: 10.3390/ijms22094339] [Reference Citation Analysis]
3 Greene MK, Johnston MC, Scott CJ. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. Cancers (Basel) 2021;13:6175. [PMID: 34944794 DOI: 10.3390/cancers13246175] [Reference Citation Analysis]
4 Liao W, Clift AK, Patone M, Coupland C, González-Izquierdo A, Pereira SP, Hippisley-Cox J. Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population. Br J Gen Pract 2021;71:e836-45. [PMID: 34544691 DOI: 10.3399/BJGP.2021.0153] [Reference Citation Analysis]
5 Stornello C, Archibugi L, Stigliano S, Vanella G, Graglia B, Capalbo C, Nigri G, Capurso G. Diagnostic delay does not influence survival of pancreatic cancer patients. United European Gastroenterol J 2020;8:81-90. [PMID: 32213057 DOI: 10.1177/2050640619879004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]